Anderson, S. L. (1998). The biological basis of mental illness. In C. A. Glod (Ed.), Contemporary psychiatric-mental health nursing: The brain-behavior connection (pp. 75-90). Philadelphia: Davis.
2.
Bhatara, V. S., Magnus, R. D., Paul, K. L., & Preskorn, S. H. (1998). Serotonin syndrome induced by venlafaxine and fluoxetine: A case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. Annals of Pharmacotherapy, 32, 432-436.
3.
Brown, T. M., Skop, B. P., & Mareth, T. R. (1996). Pathophysiology and management of the serotonin syndrome. The Annals of Pharmocotherapy, 5, 527-533.
4.
deGroot, J., & Chusid, J. G. (1988). Correlative neuroanatomy (20th ed.). East Norwalk, CT: Appleton & Lange.
5.
Demirkiran, M., Jankovic, J., & Dean, J. M. (1996). Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome. Clinical Neuropharmacology, 19, 157-164.
6.
Dubovsky, S. L., & Thomas, M. (1995). Serotonergic mechanisms and current and future psychiatric practice. Journal of Clinical Psychiatry, 56(Suppl. 2), 38-48.
7.
Fink, M. (1996). Toxic serotonin syndrome or neuroleptic malignant syndrome?Pharmacopsychiatry, 29, 159-161.
8.
Goth, A. (1981). Medical pharmacology (10th ed.). St. Louis, MO: Mosby.
9.
Hegerl, U., Bottlender, R., Gallinat, J., Kuss, H. J., Ackenheil, M., & Moller, H. J. (1998). The Serotonin Syndrome Scale: First results on validity. European Archives of Psychiatry and Clinical Neuroscience, 248, 96-103.
10.
Ivanusa, Z., Demarin, V., & Hecimovic, H. (1997). Serotonin syndrome. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 10(3), 209-212.
11.
Kaplan, H., & Sadock, B. (1996). Comprehensive textbook ofpsychiatry/ V7 (6th ed.). Baltimore, MD: Williams and Wilkins.
12.
Kaplan, H., Sadock, B., & Grebb, J. A. (1994). Synopsis of psychiatry (7th ed.). Baltimore, MD: Williams and Wilkins.
13.
LoCurto, M. J. (1997). The serotonin syndrome. Emergency Medicine Clinics of North America, 15, 665-666.
14.
Mills, K. C. (1997). Serotonin syndrome: A clinical update. Critical Care Clinics, 13, 763-783.
15.
Mitchell, P. B. (1997). Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Safety, 17, 390-406.
16.
Molaie, M. (1997). Serotonin syndrome presenting with migrainelike stroke. Headache, 37, 519-521.
17.
Snyder, S. (1986). Drugs and the brain. New York: Scientific American Books.
18.
Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry, 148, 705-713.
19.
Stahl, S. M. (1996). Essential psychopharmacology. London; Cambridge University Press.
20.
Weiner, L. A., Smythe, M., & Cisek, J. (1998). Serotonin syndrome secondary to phenelzine-venlafaxine interaction. Pharmacotherapy, 18, 399-403.
